We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 30, 2021

Budesonide for PBC After Insufficient Response to UDCA

Journal of Hepatology


Additional Info

Journal of Hepatology
A Placebo-Controlled Randomised Trial of Budesonide for PBC Following an Insufficient Response to UDCA
J. Hepatol. 2021 Feb 01;74(2)P321-329, GM Hirschfield, U Beuers, L Kupcinskas, P Ott, A Bergquist, M Färkkilä, MP Manns, A Parés, U Spengler, M Stiess, R Greinwald, M Pröls, D Wendum, U Drebber, R Poupon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading